{"id":106769,"name":"BAUDAX BIO, INC. (FORMERLY KNOWN AS RECRO PHARMA, INC.)","slug":"baudax-bio-inc-formerly-known-as-recro-pharma-inc","state":"PA","country":"United States of America","description":"&#226;€‹Pharmaceuticals","totalSpending":920000,"filings":19,"yearlySpending":[{"year":2019,"income":240000},{"year":2020,"income":240000},{"year":2021,"income":240000},{"year":2022,"income":200000},{"year":2023,"income":0}],"issues":["HCR"],"firms":["BGR GOVERNMENT AFFAIRS"],"lobbyists":["DAVID BOYER","BRENT DEL MONTE","ROBB WALTON","JOHN STONE","MATT HOFFMANN","REMY MASON","DANIEL FARMER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Recro Pharma specifically.","Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Recro Pharma specifically.","Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Recro Pharma specifically.","Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Recro Pharma specifically.","Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Recro Pharma specifically."],"years":[2019,2020,2021,2022,2023]}